Shigetada Nakanishi

Last updated
Shigetada Nakanishi
Shigetada Nakanishi cropped 1 Shigetada Nakanishi 201511.png
Shigetada Nakanishi
Born (1942-01-07) January 7, 1942 (age 82)
Alma mater Kyoto University
Awards Asahi Prize (1983)
Keio Medical Science Prize (1996)
Imperial Prize of the Japan Academy (1997)
Gruber Prize in Neuroscience (2007)
Scientific career
Fields Neuroscience
Institutions Kyoto University
Osaka Bioscience Institute
Doctoral students Yoshiki Sasai

Shigetada Nakanishi (born January 7, 1942 [1] ) is a Japanese biochemist and neuroscientist. Both a medical doctor and biomedical researcher by training, Nakanishi is the director of the Osaka Bioscience Institute and professor emeritus at Kyoto University. He has received several scientific awards for his research in neuroscience, having characterized the molecular structure or function of several protein receptors.

Contents

He is a foreign associate of the National Academy of Sciences and a foreign honorary member of the American Academy of Arts and Sciences in the U.S.

Early life

Nakanishi grew up in Ōgaki in rural central Japan. He earned a medical degree at Kyoto University and, though his family hoped that he would enter medical practice, he continued his studies for a Ph.D. and opted for a research career. [2] Nakanishi said that he considered clinical medicine, but he was swayed toward research as he realized that many modern medical conditions were still not well understood from a basic science perspective. [3]

Career

Nakanishi came to the U.S. in 1971 and was a visiting associate at National Cancer Institute Laboratory of Molecular Biology. In 1974, Nakanishi joined the faculty at Kyoto University. [4] He said that early in his career, there was growing interest in the impact of various enzymes on metabolic processes in cells, but he said that he saw an opportunity in that the underlying protein chemistry of enzymes still was not very well understood. [3] In 2005, Nakanishi was named an emeritus professor at Kyoto and he became director of the Osaka Bioscience Institute. [4]

Nakanishi's research has largely focused on the molecular science behind glutamate receptors. [4] Using electrophysiology and the Xenopus oocyte expression system, Nakanishi's team was able to isolate receptors and ion channels. The team was the first to characterize the molecular structure of NMDA receptors and metabotropic glutamate receptors. The research suggested that specific types of receptors had varying functions in different parts of the brain. [5]

Nakanishi has also been able to detail the structure of receptors for Substance P, Substance K, neurotensin and endothelin. The work with Substance K represented the first time that the structure of a peptide receptor had been elucidated. [5] Modifying a technique invented by a National Cancer Institute colleague, Nakanishi has applied cell ablation to the study of neuroscience. In Nakanishi's version of cell ablation, he is able to eliminate specific nerve cell types one at a time, which aids in the study of brain function, dysfunction and compensation. [2]

In the spring of 2012, Nakanishi announced that the city of Osaka was planning to cut off funding to the Osaka Bioscience Institute as part of a city renewal plan. Nakanishi said that he had not received any communication from the city before the plan was announced. The institute was expected to close within four years. [6]

Honors and awards

Nakanishi won the Asahi Prize in 1983. [3] He was named a foreign honorary member of the American Academy of Arts and Sciences in 1995. [7] The next year, he received the Keio Medical Science Prize. [4] In 1997, Nakanishi won the Imperial Prize of the Japan Academy. [3] He was named a Person of Cultural Merit in Japan in 2006, and he won the 2007 Gruber Prize in Neuroscience. [2] He has also been named a foreign associate of the US National Academy of Sciences and has received the Bristol-Myers Squibb Award for Distinguished Achievement in Neuroscience. [5] He chairs the executive committee of the Kyoto Prize. [8]

Related Research Articles

Ronald Mark Evans is an American Biologist, Professor and Head of the Salk’s Gene Expression Laboratory, and the March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute for Biological Studies in La Jolla, California and a Howard Hughes Medical Institute Investigator. Dr. Ronald M. Evans is known for his original discoveries of nuclear hormone receptors (NR), a special class of transcriptional factor, and the elucidation of their universal mechanism of action, a process that governs how lipophilic hormones and drugs regulate virtually every developmental and metabolic pathway in animals and humans. Nowadays, NRs are among the most widely investigated group of pharmaceutical targets in the world, already yielding benefits in drug discovery for cancer, muscular dystrophies, osteoporosis, type II diabetes, obesity, and cardiovascular diseases. His current research focuses on the function of nuclear hormone signaling and their function in metabolism and cancer.

<span class="mw-page-title-main">Susumu Tonegawa</span> Japanese scientist (born 1939)

Susumu Tonegawa is a Japanese scientist who was the sole recipient of the Nobel Prize for Physiology or Medicine in 1987 for his discovery of V(D)J recombination, the genetic mechanism which produces antibody diversity. Although he won the Nobel Prize for his work in immunology, Tonegawa is a molecular biologist by training and he again changed fields following his Nobel Prize win; he now studies neuroscience, examining the molecular, cellular and neuronal basis of memory formation and retrieval.

<span class="mw-page-title-main">Osaka University</span> Public university in Osaka, Japan

Osaka University, abbreviated as OU or Handai (阪大), is a national research university in Osaka, Japan. The university traces its roots back to Edo-era institutions Tekijuku (1838) and Kaitokudo (1724), and was officially established in 1931 as the sixth of the Imperial Universities in Japan, with two faculties: science and medicine. Following the post-war educational reform, it merged with three pre-war higher schools, reorganizing as a comprehensive university with five faculties: science, medicine, letters, law and economics, and engineering. After the merger with Osaka University of Foreign Studies in 2007, Osaka University became the largest national university in Japan by undergraduate enrollment.

<span class="mw-page-title-main">Tadamitsu Kishimoto</span> Japanese immunologist (born 1939)

Tadamitsu Kishimoto is a Japanese immunologist known for research on IgM and cytokines, most famously, interleukin 6.

Masaru Tomita is a Japanese scientist in the fields of systems biology and computer science, best known as the founder of the E-Cell simulation system and/or the inventor of GLR parser algorithm. He served a professor of Keio University, Director of the Institute for Advanced Biosciences, and the founder and board member of various spinout companies, including Human Metabolome Technologies, Inc. and Spiber Inc. He is also the co-founder and on the board of directors of The Metabolomics Society. His father was the renowned composer and synthesiser pioneer Isao Tomita.

The Gruber Prize in Neuroscience, established in 2004, is one of three international awards worth US$500,000 made by the Gruber Foundation, a non-profit organization based in Yale University in New Haven, Connecticut.

<span class="mw-page-title-main">Koji Nakanishi</span> Japanese chemist (1925–2019)

Koji Nakanishi was a Japanese chemist who studied bioorganic chemistry and natural products. He served as Centennial Professor of Chemistry and chair of the Chemistry Department at Columbia University.

<span class="mw-page-title-main">Osamu Hayaishi</span> Japanese biochemist

Osamu Hayaishi MJA, was a Japanese biochemist, physiologist, and military physician. He discovered Oxygenases at the National Institute of Arthritis and Metabolic Diseases, National Institutes of Health in 1955.

<span class="mw-page-title-main">Metabotropic glutamate receptor 7</span> Mammalian protein found in humans

Metabotropic glutamate receptor 7 is a protein that in humans is encoded by the GRM7 gene.

<span class="mw-page-title-main">Shizuo Akira</span> Japanese immunologist

Shizuo Akira is a professor at the Department of Host Defense, Osaka University, Japan. He has made ground-breaking discoveries in the field of immunology, most significantly in the area of innate host defense mechanisms.

Richard Lewis Huganir is a Bloomberg Distinguished Professor in the Departments of Neuroscience and Psychological and Brain Sciences, Director of the Solomon H. Snyder Department of Neuroscience, and co-director of the Johns Hopkins Medicine Brain Science Institute at the Johns Hopkins University School of Medicine. He has joint appointments in the Department of Biological Chemistry and the Department of Pharmacology and Molecular Sciences in the Johns Hopkins School of Medicine.

<span class="mw-page-title-main">Thomas C. Südhof</span> German-American biochemist

Thomas Christian Südhof, ForMemRS, is a German-American biochemist known for his study of synaptic transmission. Currently, he is a professor in the school of medicine in the department of molecular and cellular physiology, and by courtesy in neurology, and in psychiatry and behavioral sciences at Stanford University.

<span class="mw-page-title-main">Karl Deisseroth</span> American optogeneticist (born 1971)

Karl Alexander Deisseroth is an American scientist. He is the D.H. Chen Foundation Professor of Bioengineering and of psychiatry and behavioral sciences at Stanford University.

<span class="mw-page-title-main">Yoshinori Ohsumi</span> Japanese cell biologist

Yoshinori Ohsumi is a Japanese cell biologist specializing in autophagy, the process that cells use to destroy and recycle cellular components. Ohsumi is a professor at Tokyo Institute of Technology's Institute of Innovative Research. He received the Kyoto Prize for Basic Sciences in 2012, the 2016 Nobel Prize in Physiology or Medicine, and the 2017 Breakthrough Prize in Life Sciences for his discoveries of mechanisms for autophagy.

<span class="mw-page-title-main">Shigekazu Nagata</span> Japanese biochemist

Shigekazu Nagata is a Japanese biochemist, best known for research on apoptosis, the process of programmed cell death occurring in multi-cellular organisms.

<span class="mw-page-title-main">Tasuku Honjo</span> Japanese immunologist and Nobel laureate (born 1942)

Tasuku Honjo is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1). He is also known for his molecular identification of cytokines: IL-4 and IL-5, as well as the discovery of activation-induced cytidine deaminase (AID) that is essential for class switch recombination and somatic hypermutation.

<span class="mw-page-title-main">Shimon Sakaguchi</span>

Shimon Sakaguchi is an immunologist and a Distinguished Professor of Osaka University. He is best known for the discovery of regulatory T cells and to describe their role in the immune system. This discovery is used in the treatment of cancer and autoimmune diseases.

<span class="mw-page-title-main">Iain Mattaj</span> British scientist

Iain William Mattaj FRS FRSE is a British scientist and Honorary Professor at Heidelberg University in Germany. From 2005 to 2018 he was Director General of the European Molecular Biology Laboratory (EMBL). He stepped down from the position at the end of 2018 following his appointment to Human Technopole. In January 2019 he took office as the first Director of Human Technopole, the new Italian institute for life sciences in Milan, Italy.

Stephen F. Heinemann (1939–2014) was a professor of neuroscience at the Salk Institute. He was an early researcher in the field of molecular neuroscience, contributing to the current knowledge of how nerves communicate with each other, and the role of neurotransmitters. Stephen Heinemann died August 6, 2014, of kidney failure.

<span class="mw-page-title-main">Masashi Yanagisawa</span> Japanese molecular biologist

Masashi Yanagisawa is a Japanese-American molecular biologist and physician, famous for his discovery of the hormone endothelin and the neuropeptide orexin, the absence of which is the cause of narcolepsy. He is currently the Director of the International Institute for Integrative Sleep Medicine, University of Tsukuba, and an adjunct professor at the Department of Molecular Genetics, University of Texas Southwestern Medical Center.

References

  1. "中西重忠(なかにし しげただ)とは". 日本人名大辞典+Plus (in Japanese). Asahi Shinbun. Retrieved 23 November 2016.
  2. 1 2 3 "Shigetada Nakanishi". Gruber Foundation . Retrieved November 12, 2016.
  3. 1 2 3 4 "Making discoveries by introducing new methodologies". Biohistory Journal. No. Summer 2007. Retrieved November 12, 2016.
  4. 1 2 3 4 "Keio Medical Science Prize 1996". International Awards in Medicine and Life Science | Awards & Honors (in Japanese). Retrieved November 12, 2016.
  5. 1 2 3 Craighead, W. Edward; Nemeroff, Charles B. (2002). The Corsini Encyclopedia of Psychology and Behavioral Science. John Wiley & Sons. p. 1003. ISBN   9780471270829.
  6. "Osaka Bioscience Institute fights for survival". blogs.nature.com. May 22, 2012. Retrieved November 12, 2016.
  7. "N: Shigetada Nakanishi" (PDF). American Academy of Arts and Sciences . Retrieved November 12, 2016.
  8. "Kyoto Prize Executive Committee". Kyoto Prize . Retrieved November 12, 2016.